Selected Recent Cross-Border Transactions

in the demerger of Haleon from GSK and its subsequent listing on the London Stock Exchange

Jun 2022

in its acquisition of certain entities of

Apr 2022
€160 million

in its acquisition of

Apr 2022

in its acquisition by a consortium led by

Mar 2022
$16 billion

in its cash and share acquisition of

Feb 2022
£965 million

in its transfer of certain intellectual property rights to Mr. Cooper's cloud-based technology platform for mortgage servicing to Sagent M&C, in exchange for a minority stake in

Feb 2022

in its equity investment in

Jan 2022
$760 million

in its business combination with

Jan 2022
$2.64 billion


Page 3 of 13